KOSS-OLINGER CONSULTING, LLC Catalyst Pharmaceuticals, Inc. Transaction History

KOSS-OLINGER CONSULTING, LLC portfolio value:

$291,000
portfolio value

KOSS-OLINGER CONSULTING, LLC quarter portfolio value change:

+83.02%
quarter

Catalyst Pharmaceuticals, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase +19.84% 3.75K shares 158K $12.83 22.66K
Q2 2022 share Increase +25.35% 3.82K shares 8K $7.01 18.90K
Q1 2022 share Increase +44.76% 4.66K shares 54K $8.29 15.08K
Q4 2021 share Increase 0.00% 10.42K shares 71K $6.89 10.42K